Sign Up to like & get
recommendations!
3
Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34657
Abstract: The authors report results from the thyroid carcinoma cohort of the multicohort phase 2 KEYNOTE‐158 study (NCT02628067), which evaluated pembrolizumab monotherapy in patients with previously treated cancers.
read more here.
Keywords:
keynote 158;
158 study;
phase keynote;
pembrolizumab monotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.tps4590
Abstract: TPS4590Background: Only 5%-15% of patients (pts) with advanced bladder cancer attain long-term survival with standard first-line cisplatin-based chemotherapy. Programmed death 1 (PD-1)/PD-L1 inhibi...
read more here.
Keywords:
chemotherapy;
361 trial;
keynote 361;
cancer ... See more keywords